Induced pluripotent stem cells: origins, applications, and future perspectives

Area of Science:

• Stem cell biology
• Regenerative medicine
• Genetics

Background:

• Embryonic stem (ES) cells offer therapeutic potential but face ethical challenges due to their source.
• Induced pluripotent stem (iPS) cells were developed to overcome these ethical limitations.
• iPS cells are derived from somatic cells, avoiding the use of embryos.

Purpose of the Study:

• To review the generation and applications of induced pluripotent stem (iPS) cells.
• To discuss the advantages of using peripheral blood for iPS cell generation.
• To explore the future perspectives and potential issues associated with iPS cell technology.

Main Methods:

• Review of existing literature on induced pluripotent stem (iPS) cell generation and applications.
• Focus on reprogramming somatic cells, including peripheral blood.
• Analysis of current and potential uses in therapy, disease modeling, and drug discovery.

Main Results:

• iPS cells can be generated from various somatic cell types, including peripheral blood, which offers safety and accessibility advantages.
• iPS cell technology has demonstrated significant progress in applications like cell therapy, disease modeling, and drug discovery.
• The review covers the evolution from initial generation to diverse applications of iPS cells.

Conclusions:

• Induced pluripotent stem (iPS) cells provide a promising ethical alternative to embryonic stem (ES) cells.
• Peripheral blood is a valuable source for generating iPS cells, facilitating research and clinical applications.
• iPS cells hold substantial potential for future advancements in regenerative medicine and personalized therapies.